Skip to content
Screener

United Therapeutics UTHR Prepaid & Other Current

Prepaid & Other Current at other companies

Tenet Healthcare logo
Tenet HealthcareTHC
$338M-6.6%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$4.83B+10.7%
Merck & Co. logo
Merck & Co.MRK
$10.77B+7.7%
Insmed logo
InsmedINSM
$115.9M+86.4%
LQD
Liquidia CorporationLQDA
$7.61M+56.8%
Amgen logo
AmgenAMGN
$4.53B+32.2%

Other financials

Income statement

See full
Revenue$783.3M-1.9%
Gross profit$683.8M-3.8%
Operating income$330.8M-9.2%
Net income$333.0M+7.6%
EPS (diluted)$7.27+13.4%

Balance sheet

See full
Cash & equivalents$1.8B+13.2%
Total debt$12.2M
Total equity$6.4B-10.8%
Total assets$7.2B-8.7%

Cash flow

See full
Operating cash flow$313.6M+63.6%
CapEx$108.0M+73.6%
Free cash flow$205.6M+58.8%

Valuation

See full
Market cap$22.03B+61.1%
P/E16.8×+5.8×
P/S+2.5×

Profitability

See full
Gross margin86.1%-2.8pp
Operating margin44.4%-2.6pp
Net margin41.6%+1.2pp
FCF margin34.6%-0.1pp

Returns & leverage

See full
Return on equity19.3%0.0pp
Debt / equity
Current ratio5.7×-1.5×

Where this comes from

Reported directly by United Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsCurrent.

The source filing: United Therapeutics’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 6:31 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001082554-26-000027
Line itemJune 30, 2026December 31, 2025
Marketable investments859.11,363.2
Accounts receivable, no allowance for 2026 and 2025310.3350.2
Inventories, net193.8183.1
Other current assets317.3248.9
Total current assets3,483.73,702.5
Marketable investments1,141.11,776.7
Goodwill and other intangible assets, net114.1116.5
Property, plant, and equipment, net1,930.11,729.7

Item 1. Consolidated Financial Statements

FAQ

What is United Therapeutics's prepaid & other current?
United Therapeutics (UTHR) reported prepaid & other current of $317.3M in Q2 2026.
How has United Therapeutics's prepaid & other current changed year-over-year?
United Therapeutics's prepaid & other current increased by 38.1% year-over-year, from $229.7M to $317.3M.
What is the long-term trend for United Therapeutics's prepaid & other current?
Over 5 years (2020 to 2025), United Therapeutics's prepaid & other current has grown at a 23.0% compound annual growth rate (CAGR), from $88.3M to $248.9M.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.

Ask your AI about United Therapeutics's prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude